Medicare Part D Rebate Pass-Throughs To Beneficiaries Is 'On The Table'
Lilly CEO David Ricks reflects on the state of play on drug pricing issues on Capitol Hill and in the Administration and the challenges he sees ahead.
You may also be interested in...
CMS outlines possible approach to point-of-sale rebates in Medicare Part D, recognizing that using rebates to lower cost sharing for 'many' would increase premiums for all.
Upcoming proposed rule on Medicare Part D and Medicare Advantage prompts speculation about whether CMS is planning new measures to control spending on prescription drugs.
News that premiums will be lower in 2018 aligns with President Trump's concern with lowering drug costs, Administration officials announce.